Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients-Reference-Cited by-同舟云学术

Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients

Published:2009-07-01 Issue:13 Volume:115 Page:2980-2987
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Massimo Berger,Giovanni Grignani,Stefano Ferrari,Eleonora Biasin,Adalberto Brach del Prever,Sandra Aliberti,Francesco Saglio,Massimo Aglietta,Franca Fagioli

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24368/fullpdf

Reference42 articles.

1. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol;Meyers;J Clin Oncol.,1998

2. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group;Provisor;J Clin Oncol.,1997

3. Randomised trial of 2 regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup;Souhami;Lancet.,1997

4. Neoadjuvant chemotherapy for extremity osteosarcoma-preliminary results of the Rizzoli's 4th study;Bacci;Acta Oncol.,1998

5. Primary bone osteosarcoma in the pediatric age: state of the art;Longhi;Cancer Treat Rev.,2006

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study;BMC Cancer;2024-06-19

2. Knochensarkome;Therapie-Handbuch - Onkologie und Hämatologie;2024

3. European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma;EJC Paediatric Oncology;2023-12

4. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization;Cellular Oncology;2023-09-07

5. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization;2023-07-10